Sepideh Parvizpour, Jafar Razmara, Mohammad M. Pourseif, Yadollah Omidi* 
Using
immunoinformatic tools, a multi-epitope peptide vaccine (consisting of CD8+cytotoxic T lymphocytes epitopes, helper epitopes and
adjuvant) was designed to combat the triple-negative breast cancer. The vaccine
showed acceptable immunogenicity and potential to stimulate both cellular and
humoral immune responses.
|
Ysrafil Ysrafil* , Zulfiayu Sapiun , Indwiani Astuti , Mohammad Anas Anasiru, Nangsih Sulastri Slamet , Hartati Hartati , Fadli Husain, Sukmawati Ahmad Damiti
The two designed and constructed multiepitope vaccine have good characteristics and may have the potential to activate humoral and cellular immune responses against SARS-CoV-2. Further research is worth considering to confirm the findings of this study.
|
Maryam Rezaei , Mehri Habibi, Parasoo Ehsani, Mohammad Reza Asadi Karam*, Saeid Bouzari*
|
Marzieh Shokoohi* , Ara Manteghi Tafreshi, Milad Mokarami , Saeedeh Akhavan , Reza Mohammadhassan*
|
Mohamed J. Saadh , Mareb Hamed Ahmed* , Rafid Jihad Albadr, Gaurav Sanghvi, R. Roopashree, Aditya Kashyap, A. Sabarivani, Zafar Aminov, Waam Mohammed Taher, Mariem Alwan, Mahmod Jasem Jawad, Ali M. Ali Al-Nuaimi
|